AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Doctor wearing surgical mask

Congress extends Dr. Lorna Breen law for five years

| 4 Min Read
Rebekah Bernard, MD

With expanded scope, where do NPs practice? It’s not primary care

| 5 Min Read
Prescription pill bottle with pills surrounded in a circle

Targeted PBM reforms aim to boost fairness, lower costs

| 4 Min Read
Gears with icons symbolizing business, success, teamwork

Medical student’s research on overdose training wins $10,000 prize

| 6 Min Read